microdosing retatrutide daily GLP-1 Medications What is the optimal micro‑dosing

For retatrutide, published descriptions characterise it as a triple agonist engaging GLP-1, GIP, and glucagon receptors

Iqbal N, Seshadri P, Stern L, et al

Substantial weight regain after discontinuation highlights the need to shift focus from short-term weight loss to long-term behavioral stabilization

She was in pain, developing multiple flare-ups per month, and with no energy

Preproglucagon Neurons in the Nucleus of the Solitary Tract Are the Main Source of Brain GLP-1, Mediate Stress-Induced Hypophagia, and Limit Unusually Large Intakes of Food

Although the findings are encouraging, scientists say larger studies are needed before concluding that the medication can help people age more slowly